# Development of a Shared System REMS Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/development-of-a-shared-system-rems-guidance-for-industry/b67470fa-28bc-4644-aeba-c9afd830c0cd

> FDA guidance document: Development of a Shared System REMS Guidance for Industry. Issue date: June 01, 2018. Get complete insights and analysis.

---

## Details

- Title: Development of a Shared System REMS Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-06-01
- Comment Close Date: 2018-07-31
- Last Changed: 2020-04-16
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-1041">FDA-2018-D-1041</a>

## Related Documents

- [Drug Master Files Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-master-files-guidance-for-industry/7dfd5140-3156-43f2-bdb9-d23ad597311c)
- [Biomarker Qualification: Evidentiary Framework: Draft Guidance for Industry and FDA Staff](https://www.globalkeysolutions.net/guidances/guidance-document/biomarker-qualification-evidentiary-framework-draft-guidance-for-industry-and-fda-staff/c198796d-4230-4499-a6ee-2f84eed424c9)
- [Use of a Drug Master File for Shared System REMS Submissions Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/use-of-a-drug-master-file-for-shared-system-rems-submissions-guidance-for-industry/bdcae9f2-6712-48b2-afb3-be17664f8562)